UM

Browse/Search Results:  1-10 of 17 Help

Selected(0)Clear Items/Page:    Sort:
F-18-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study Journal article
ONCOLOGY LETTERS, 2019,Volume: 17,Issue: 1,Page: 149-158
Authors:  Dang, Ya-Zheng;  Li, Xin;  Ma, Yu-Xin;  Li, Xiao-Long;  Yang, Ting;  Lu, Wan-Ling;  Huang, Shi-Gao
Favorite  |  View/Download:0/0  |  Submit date:2019/01/17
ovarian cancer  radiation therapy  positron emission tomography  computed tomography  intensity-modulated radiotherapy  
Technical Note: Virtual CT for reducing CT dose in targeted radionuclide therapy dosimetry Journal article
Medical Physics, 2018,Volume: 45,Issue: 11,Page: 5138-5144
Authors:  Li T.;  Mok G.S.P.
Favorite  |  View/Download:4/0  |  Submit date:2018/12/18
Image Registration  Internal Dosimetry  Spect/ct  Targeted Radionuclide Therapy  
Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells Journal article
CHINESE MEDICINE, 2018,Volume: 13
Authors:  Zhong, Zhangfeng;  Yu, Haibing;  Wang, Shengpeng;  Wang, Yitao;  Cui, Liao
View  |  Adobe PDF(2911Kb)  |  Favorite  |  View/Download:113/9  |  Submit date:2018/10/30
Rhizoma Curcumae  Multidrug Resistance  Breast Cancer  Abc Transporters  Furanodiene  
Physalin B induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway Journal article
BIOMEDICINE & PHARMACOTHERAPY, 2018,Volume: 101,Page: 334-341
Authors:  Wang, Anqi;  Wang, Shengpeng;  Zhou, Fayang;  Li, Peng;  Wang, Yitao;  Gan, Lishe;  Lin, Ligen
View  |  Adobe PDF(1614Kb)  |  Favorite  |  View/Download:105/11  |  Submit date:2018/10/30
Physalin b  Breast Cancer  Cell Cycle  Apoptosis  P53  Akt  
Comparison of different Tc-99m-MAA imaging protocols for Y-90 SIRT treatment planning Conference paper
J Nucl Med, Atlanta, GA, USA, October 21 – 28, 2017
Authors:  Mingren Feng;  Tiantian Li;  Nien-Yun Wu;  Greta Mok
Favorite  |  View/Download:2/0  |  Submit date:2019/01/28
Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo Conference paper
Authors:  Ye, Jie;  Yuen, Shun Ming;  Murphy, Gillian;  Xie, Ruiyu;  Kwok, Hang Fai
Favorite  |  View/Download:5/0  |  Submit date:2018/10/31
Pancreatic ductal adenocarcinoma (PDAC)  ADAM17  Inhibitory antibody  Tumorigenesis  Targeted therapy  
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo Journal article
European Journal of Pharmaceutical Sciences, 2017,Volume: 110,Page: 62-69
Authors:  Ye J.;  Yuen S.M.;  Murphy G.;  Xie R.;  Kwok H.F.
Favorite  |  View/Download:2/0  |  Submit date:2018/12/19
Adam17  Inhibitory Antibody  Pancreatic Ductal Adenocarcinoma (Pdac)  Targeted Therapy  Tumorigenesis  
Venom Peptides and Toxins - A Prospective Spearhead in Cancer Treatment Journal article
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017,Volume: 20,Issue: 5,Page: 357-375
Authors:  Wong, Janet P. C.;  Li, Bin;  Kwok, Hang F.
Favorite  |  View/Download:14/0  |  Submit date:2018/10/30
Cancer  Venom  Reptiles  Amphibians  Insects  Plants  Conjugated Peptide  Toxin  Mechanisms  
Core-shell and co-doped nanoscale metal-organic particles (NMOPs) obtained via post-synthesis cation exchange for multimodal imaging and synergistic thermo-radiotherapy Journal article
NPG ASIA MATERIALS, 2017,Volume: 9
Authors:  Yang, Yu;  Chao, Yu;  Liu, Jingjing;  Dong, Ziliang;  He, Weiwei;  Zhang, Rui;  Yang, Kai;  Chen, Meiwan;  Liu, Zhuang
Favorite  |  View/Download:10/0  |  Submit date:2018/10/30
An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia Journal article
International Journal of Cancer Research and Molecular Mechanisms, 2017,Volume: 3,Issue: 2
Authors:  Peixian Chen;  Yeong C Kim;  Mojitaba Akhtari;  San Ming Wang
Favorite  |  View/Download:2/0  |  Submit date:2018/12/18
Exome Sequencing  Somatic Mutation  Tmds/aml  Tet2